Irina Cleemput

5.0k total citations · 1 hit paper
152 papers, 3.0k citations indexed

About

Irina Cleemput is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Irina Cleemput has authored 152 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Economics and Econometrics, 42 papers in General Health Professions and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Irina Cleemput's work include Health Systems, Economic Evaluations, Quality of Life (72 papers), Pharmaceutical Economics and Policy (33 papers) and Healthcare cost, quality, practices (17 papers). Irina Cleemput is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (72 papers), Pharmaceutical Economics and Policy (33 papers) and Healthcare cost, quality, practices (17 papers). Irina Cleemput collaborates with scholars based in Belgium, United States and Netherlands. Irina Cleemput's co-authors include Sabina De Geest, Katrien Kesteloot, Fabienne Dobbels, Steven Simoens, Laurence Kohn, Ariane Desmyttere, Kris Denhaerynck, Petra Schäfer‐Keller, Stefan Schaub and Johan Hellings and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Clinical Epidemiology.

In The Last Decade

Irina Cleemput

135 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology and mechanism of long COVID: a comprehensive review

2022 339 citations Diego Castanares‐Zapatero, Laurence Kohn et al. profile →

Peers

Countries citing papers authored by Irina Cleemput

Since Specialization

Citations

This map shows the geographic impact of Irina Cleemput's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Cleemput with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Cleemput more than expected).

Fields of papers citing papers by Irina Cleemput

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina Cleemput. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Cleemput. The network helps show where Irina Cleemput may publish in the future.

Co-authorship network of co-authors of Irina Cleemput

This figure shows the co-authorship network connecting the top 25 collaborators of Irina Cleemput. A scholar is included among the top collaborators of Irina Cleemput based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina Cleemput. Irina Cleemput is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Needs Examination, Evaluation and Dissemination (NEED): Identification of unmet health-related needs associated with Crohn’s disease 2024 ·(unknown), (unknown), (unknown), (unknown), Yan Zhi Tan, (unknown), (unknown), Robby De Pauw, Laurence Kohn, (unknown), (unknown), Charline Maertens de Noordhout, Irina Cleemput	0
2	Needs Examination, Evaluation and Dissemination (NEED): applicability to rare diseases 2024 ·Lirias (KU Leuven) ·(unknown), (unknown), J. F. Broekmans, (unknown), (unknown), (unknown), Rosanne Janssens, Liese Barbier, (unknown), (unknown), Robby De Pauw, Laurence Kohn, (unknown), (unknown), Irina Cleemput, Charline Maertens de Noordhout, (unknown)	1
3	Compulsory licensing for expensive medicines 2022 ·Esther van Zimmeren, Timo Minssen, (unknown), Walter Van Dyck, Jeroen Luyten, Rosanne Janssens, Liese Barbier, Steven Simoens, (unknown), Irina Cleemput, (unknown)	1
4	Long COVID 2021 ·Diego Castanares‐Zapatero, Laurence Kohn, Marie Dauvrin, Jens Detollenaere, Charline Maertens de Noordhout, Célia Primus-de Jong, Irina Cleemput, Koen Van den Heede	1
5	Besoins et suivi des patients atteints de COVID long 2021 ·Diego Castanares‐Zapatero, Laurence Kohn, Marie Dauvrin, Jens Detollenaere, Charline Maertens de Noordhout, Célia Primus-de Jong, Irina Cleemput, Koen Van den Heede	1
6	Het gebruik van patiëntuitkomsten en -ervaringen (PROMs/PREMs) voor klinische en beleidsdoeleinden 2018 ·Anja Desomer, Koen Van den Heede, (unknown), James Paget, Dolf de Boer, Laurence Kohn, Irina Cleemput	2
7	Future scenarios about drug development and drug pricing 2016 ·(unknown), (unknown), (unknown), (unknown), (unknown), Irina Cleemput, Frank Hulstaert, (unknown), R. Tyler Mertens	4
8	Belgische richtlijnen voor economische evaluaties en budget impact analyses 2015 ·Irina Cleemput, (unknown), (unknown), (unknown)	1
9	Towards a better managed off-label use of drugs 2015 ·(unknown), (unknown), Mattias Neyt, Frank Hulstaert, (unknown), Irina Cleemput, (unknown)	4
10	Belgian guidelines for economic evaluations and budget impact analyses 2015 ·Irina Cleemput, (unknown), (unknown), (unknown)	11
11	Models for citizen and patient involvement in health care policy - Part I: exploration of their feasibility and acceptability 2013 ·Wendy Christiaens, Laurence Kohn, Christian Léonard, Alain Denis, (unknown), Irina Cleemput	3
12	Manual for cost-based pricing of hospital interventions 2012 ·(unknown), (unknown), Patrick Guillaume, (unknown), Irina Cleemput	7
13	Handleiding voor op-kosten-gebaseerde prijsbepaling van ziekenhuisinterventies 2012 ·(unknown), (unknown), Patrick Guillaume, (unknown), Irina Cleemput	1
14	Organisation et financement de la dialyse chronique en Belgique 2010 ·Irina Cleemput, Claire Beguin, (unknown), Sophie Gerkens, Michel Jadoul, Gert A. Verpooten, Chris De Laet	3
15	Beleid voor zeldzame ziekten en weesgeneesmiddelen 2009 ·Alain Denis, Steven Simoens, (unknown), Lut Mergaert, Irina Cleemput	1
16	Utilisation des coagulomètres portables chez les patients sous anticoagulants oraux 2009 ·(unknown), Sophie Gerkens, Ann Van den Bruel, Stephan Devriese, (unknown), Irina Cleemput	1
17	Recommandations pour les évaluations pharmacoéconomiques en Belgique 2008 ·Irina Cleemput, Philippe Van Wilder, France Vrijens, (unknown), Dirk Ramaekers	4
18	Guidelines for Pharmacoeconomic Evaluations in Belgium 2008 ·Irina Cleemput, Philippe Van Wilder, France Vrijens, (unknown), Dirk Ramaekers	18
19	Organisation et financement de la réadaptation locomotrice et neurologique en Belgique. 2007 ·Irina Cleemput, Mike Smet, Katrien Kesteloot, (unknown), (unknown), (unknown), Marijke Eyssen, Koen Putman, (unknown), Mark Leys, (unknown), Carlotte Kiekens	2
20	Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium 2006 ·Marie‐Laurence Lambert, Laurence Kohn, Mark Leys, Irina Cleemput, Dirk Ramaekers, (unknown), Joan Vlayen, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact